Back
LivePerson, Inc. 10K Form
Sell
30
LPSN
LivePerson, Inc.
Last Price:
$5.14
Seasonality Move:
-0.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | LPSN/LivePerson, Inc. Quarterly |
| 2023-11-09 | 10Q | LPSN/LivePerson, Inc. Quarterly |
| 2023-08-09 | 10Q | LPSN/LivePerson, Inc. Quarterly |
| 2023-05-11 | 10Q | LPSN/LivePerson, Inc. Quarterly |
| 2022-11-08 | 10Q | LPSN/LivePerson, Inc. Quarterly |
| 2022-08-09 | 10Q | LPSN/LivePerson, Inc. Quarterly |
Receive LPSN News And Ratings
See the #1 stock for the next 7 days that we like better than LPSN
LPSN Financial Statistics
Sales & Book Value
| Annual Sales: | $312.5M |
|---|---|
| Cash Flow: | $-9.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.14 |
| Price / Book: | 2.18 |
Profitability
| EPS (TTM): | -24.49840 |
|---|---|
| Net Income (TTM): | $-134.8M |
| Gross Margin: | $192.8M |
| Return on Equity: | -596.68% |
| Return on Assets: | -22.38% |
LivePerson, Inc. Earnings Forecast
Key LivePerson, Inc. Financial Ratios
-
The Gross Profit Margin over the past 27 years for LPSN is 61.70%.
-
The Selling, General & Administrative Expenses for LPSN have been equal to 57.76% of Gross Profit Margin.
-
The Research & Development expenses have been 25.53% of Revenue.
-
The Net Earning history of LPSN is -42.97% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 12 years.
LivePerson, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | LPSN |
| CUSIP: | 538146 |
| Website: | liveperson.com |
Debt
| Debt-to-Equity Ratio: | -275.91 |
|---|---|
| Current Ratio: | 1.18 |
| Quick Ratio: | 1.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LPSN Technical Analysis vs Fundamental Analysis
Sell
30
LivePerson, Inc. (LPSN)
is a Sell
Is LivePerson, Inc. a Buy or a Sell?
-
LivePerson, Inc. stock is rated a SellThe current LivePerson, Inc. [LPSN] share price is $5.14. The Score for LPSN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.